Latest from The Spokesman-Review
Here's a news item from the Associated Press: BOISE, Idaho (AP) — Big pharmaceutical company Johnson & Johnson is paying $1.3 million to Idaho as part of a multi-billion-dollar national settlement over allegations it illegally promoted an antipsychotics drug. The Idaho attorney general's office announced the deal with the company's Janssen Pharmaceuticals unit on Monday. It resolves allegations that Janssen unlawfully induced doctors and pharmacists to promote and prescribe Risperdal, a drug approved by the federal government for adults with mental illnesses starting in 1993. In total, Johnson & Johnson is paying over $2.2 billion to resolve criminal and civil allegations the company promoted powerful psychiatric drugs for unapproved uses in children, seniors and disabled patients. The agreement is the third-largest U.S. settlement with a drug maker and the latest in several actions against drug companies allegedly putting profits ahead of patients.
Idaho will recover nearly $420,000 from an Indian generic drug manufacturer who admitted selling drugs of inferior strength, purity or quality in the United States, including through Idaho's Medicaid program. It's part of a $350 million national settlement between the federal government, the states and the company, which also pleaded guilty to seven felony counts and will pay $150 million in criminal fines and forfeitures. “Taxpayers expect their tax dollars to be used to pay for a legitimate service,” Idaho Attorney General Lawrence Wasden said. “This settlement reflects our resolve to address losses to the Idaho Medicaid program caused by individuals and companies.” Click below for Wasden's full announcement; Idaho's share includes just under $210,000 to reimburse its Medicaid program, and just over $218,000 for the state's general fund.
Pharmaceutical manufacturer GlaxoSmithKline LLC will pay Idaho $1.33 million as part of a 38-state settlement over its promotion of its diabetes drug, Avandia. Idaho Attorney General Lawrence Wasden and 38 other state attorneys general contended that the firm claimed the drug had cardiovascular benefits, when it actually may increase cardiovascular risks. The firm admitted no wrongdoing, but it agreed to change its marketing practices for the drug and to pay $90 million to the states to resolve the lawsuit. Click below for Wasden's full announcement. The money will go to Idaho's consumer protection account, where it's subject to legislative appropriation.
Idaho will receive $2,847,890 as its share of a multistate drug settlement, Idaho Attorney General Lawrence Wasden announced today; the $181 million settlement with Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is over improper marketing of four anti-psychotic drugs. The company allegedly pushed the drugs for unapproved off-label uses; as part of the settlement with 37 states, Janssen admitted no wrongdoing, but agreed to change how it markets the drugs and refrain from false, misleading or deceptive promotions. Idaho's share of the settlement will go to the Attorney General's consumer protection account; click below for Wasden's full announcement.
Here's a news item from the Associated Press: BOISE, Idaho (AP) ― Idaho has reached a $1.7 million settlement with a pharmaceutical company over allegations of excessive wholesale prices paid by the state's Medicaid program. Attorney General Lawrence Wasden announced the deal Monday with Watson Pharmaceuticals Inc., and Watson Pharma, Inc. Watson is among the top four generic drug companies in the world. Wasden sued the company in 2007 seeking to recover taxpayer money used to pay high prices charged to Idaho Medicaid for prescription drugs. Before filing the lawsuit, Wasden said an investigation by his office found drug companies like Watson were posting false and inflated prices for their drugs on the wholesale market. The state will use about $1.05 million to reimburse overpayments made by Medicaid; $50,000 will cover the state's investigative and legal costs; and $423,725 will go to the the state's general fund. So far, Idaho has recovered $22 million in similar lawsuits with drug makers.
Idaho will collect $1.65 million in a legal settlement with the prescription drug manufacturer Sandoz Inc. for overstating the average wholesale price of drugs, causing Idaho’s Medicaid program to overpay; among others, Sandoz manufactures a generic version of the drug Prozac. The company admits no wrongdoing in the settlement but agrees to pay; Wasden has reached six similar settlements with drug manufacturers since 2005, resulting in payments of another $7 million to Idaho taxpayers. Three more average wholesale price cases, involving two dozen other drug manufacturers, still are pending. Click below to read Wasden’s full announcement.